Excess Salt Triggers Immune Signal That Prematurely Ages Blood Vessels, Mouse Study Finds

A high-salt diet does not damage arteries directly but instead triggers an immune response that causes blood vessel cells to age prematurely. Researchers found that this process, known as vascular senescence, leads to significant endothelial dysfunction in mice. The study suggests that targeting specific inflammatory signals could offer new ways to treat salt-sensitive vascular diseases.

The Details

The preclinical study, published in the Journal of the American Heart Association, involved male C57BL/6J mice fed a diet containing 8% NaCl—roughly 16 times the concentration of standard mouse chow. After 28 days, the high-salt group exhibited marked endothelial dysfunction, specifically in the small mesenteric arteries, which lost their ability to relax properly. Interestingly, mice fed the same diet for only 14 days did not show these effects, indicating a cumulative threshold for the damage.

To determine the cause, researchers exposed endothelial cells directly to high sodium in laboratory dishes for up to 96 hours. This exposure produced no increase in aging markers, proving that salt does not act as a direct toxin to the vessel walls. Instead, the damage is mediated by the immune system. Blood vessel cells from the salt-fed mice showed elevated levels of p21, p16, IL-6, and IL-1β, markers of cellular senescence where cells stop dividing and begin releasing inflammatory signals.

The study identified interleukin-16 (IL-16) as the primary mediator. Mice on the high-salt diet showed elevated levels of circulating IL-16. When applied to isolated arteries and cultured cells, IL-16 alone was sufficient to trigger p21 upregulation and endothelial dysfunction, utilizing receptors naturally present on the arteries.

Researchers tested the use of navitoclax (ABT263), a senolytic drug designed to clear aged cells. In salt-fed mice, the drug reduced senescence markers and restored the normal dilation and contractility of the mesenteric arteries. Navitoclax effectively protected nitric oxide signaling, the critical mechanism that had been disrupted by the prematurely aged cells.

Crucially, the study noted that this vascular aging occurred before the onset of obvious organ failure. Neither the high-salt diet nor the senolytic treatment produced significant kidney damage, heart remodeling, or proteinuria during the 28-day window, suggesting that blood vessel decay may be an early warning sign of systemic salt damage.

Context

The findings come at a time of significant global concern regarding sodium intake. While the American Heart Association recommends capping sodium at 2,300 mg per day, average global consumption remains significantly higher, around 9 grams. This dietary habit contributes to cardiovascular diseases, which account for an estimated 19.1 million deaths worldwide annually.

The study was conducted at the University of South Alabama College of Medicine within the Department of Physiology and Cell Biology. The research provides a more nuanced understanding of why salt is dangerous, shifting the focus from simple osmotic pressure or direct toxicity to an immune-driven inflammatory process.

However, the researchers noted several limitations. The study used only male mice and an extremely high concentration of salt that exceeds typical human intake relative to body mass. Furthermore, blood pressure was not measured, leaving it unclear how much hemodynamic stress contributed to the vascular dysfunction.

What's Next

The identification of IL-16 as a key mediator opens a potential new avenue for therapeutic intervention. The researchers suggest that targeting IL-16 signaling or utilizing senolytic drugs could provide a way to reverse or prevent vascular aging in patients with salt-sensitive hypertension.

Future research is needed to confirm whether the IL-16 pathway operates similarly in humans. Additionally, because navitoclax is an experimental cancer drug with a complex safety profile and mixed results in human trials regarding artery plaque, further testing is required before such treatments can be applied to cardiovascular health.

Researchers also aim to identify the specific cellular source of IL-16 during salt exposure, as the current study identified the mediator but not the exact immune cells responsible for producing it.